Title: Ascitis Secondary to Budd Chiari Syndrome Managed By Endovascular Stenting

Authors:Dr Hasmukh B Vora, Dr Sushruth Shetty, Dr Mahendra S Bhavsar, Dr Premal R Desai, Dr Nikhil Jillawar

 DOI:  http://dx.doi.org/10.18535/jmscr/v3i12.16

Abstract

Budd-Chiari syndrome (BCS) is an uncommon condition characterized by obstruction of the hepatic venous outflow.  Presentation varies from a completely asymptomatic condition to fulminant liver failure1. BCS is an example of post sinusoidal portal hypertension. The management can be divided into three main categories: medical, surgical, and endovascular2. The purpose of this article is to present a case of BCS with ascites managed by endovascular stenting.

References

1.      Aydinli M, Bayraktar Y. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol 2007; 13:2693–2696.

2.      Plessier A, Valla DC. Budd-Chiari syndr-ome. Semin Liver Dis 2008; 28:259–269.

3.      Hoekstra, J. and Janssen, H.L.A. Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome. Netherl J Med. 2008; 66: 334–339

4.      Valla, D.C. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003; 38: 793–803.

5. Eapen, C.E., Velissaris, D., Heydtmann, M., Gunson, B., Olliff, S., and Elias, E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006; 55: 878–884. 

Corresponding Author

Dr Sushruth Shetty

V.S. General Hospital, N.H.L.M.C, Ahmadabad, Gujarat